Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Rapid Tests versus ELISA for Screening of HIV Infection: Our Experience from a Voluntary Counselling and Testing Facility of a Tertiary Care Centre in North India.

Mehra B, Bhattar S, Bhalla P, Rawat D.

ISRN AIDS. 2014 Apr 7;2014:296840. doi: 10.1155/2014/296840. eCollection 2014.

2.

Practical guidance for nonoccupational postexposure prophylaxis to prevent HIV infection: an editorial review.

Jain S, Mayer KH.

AIDS. 2014 Jul 17;28(11):1545-54. doi: 10.1097/QAD.0000000000000301. Review.

3.

Multi-centre evaluation of the Determine HIV Combo assay when used for point of care testing in a high risk clinic-based population.

Conway DP, Holt M, McNulty A, Couldwell DL, Smith DE, Davies SC, Cunningham P, Keen P, Guy R; Sydney Rapid HIV Test Study.

PLoS One. 2014 Apr 8;9(4):e94062. doi: 10.1371/journal.pone.0094062. eCollection 2014. Erratum in: PLoS One. 2014;9(7):e103399.

4.

Failure to identify HIV-infected individuals in a clinical trial using a single HIV rapid test for screening.

Piwowar-Manning E, Fogel JM, Laeyendecker O, Wolf S, Cummings V, Marzinke MA, Clarke W, Breaud A, Wendel S, Wang L, Swanson P, Hackett J Jr, Mannheimer S, Del Rio C, Kuo I, Harawa NT, Koblin BA, Moore R, Blankson JN, Eshleman SH.

HIV Clin Trials. 2014 Mar-Apr;15(2):62-8. doi: 10.1310/hct1502-62.

5.

Relative accuracy of serum, whole blood, and oral fluid HIV tests among Seattle men who have sex with men.

Stekler JD, O'Neal JD, Lane A, Swanson F, Maenza J, Stevens CE, Coombs RW, Dragavon JA, Swenson PD, Golden MR, Branson BM.

J Clin Virol. 2013 Dec;58 Suppl 1:e119-22. doi: 10.1016/j.jcv.2013.09.018.

6.

Finding those at risk: acute HIV infection in Newark, NJ.

Martin EG, Salaru G, Mohammed D, Coombs RW, Paul SM, Cadoff EM.

J Clin Virol. 2013 Dec;58 Suppl 1:e24-8. doi: 10.1016/j.jcv.2013.07.016. Epub 2013 Aug 13.

7.

Use of rapid HIV assays as supplemental tests in specimens with repeatedly reactive screening immunoassay results not confirmed by HIV-1 Western blot.

Wesolowski LG, Delaney KP, Meyer WA 3rd, Blatt AJ, Bennett B, Chavez P, Granade TC, Owen M.

J Clin Virol. 2013 Sep;58(1):240-4. doi: 10.1016/j.jcv.2013.06.019. Epub 2013 Jul 6.

8.

Utility of rapid antibody tests to exclude HIV-1 infection among infants and children aged <18 months in a low-resource setting.

Buchanan AM, Nadjm B, Amos B, Mtove G, Sifuna D, Cunningham CK, Crump JA, Reyburn H.

J Clin Virol. 2012 Nov;55(3):244-9. doi: 10.1016/j.jcv.2012.08.001. Epub 2012 Aug 24.

9.

HIV nucleic acid amplification testing versus rapid testing: it is worth the wait. Testing preferences of men who have sex with men.

O'Neal JD, Golden MR, Branson BM, Stekler JD.

J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):e117-20. doi: 10.1097/QAI.0b013e31825aab51. No abstract available.

10.

Detection of Early Sero-Conversion HIV Infection Using the INSTI HIV-1 Antibody Point-of-Care Test.

Cook D, Gilbert M, Difrancesco L, Krajden M.

Open AIDS J. 2010 Dec 30;4:176-9. doi: 10.2174/1874613601004010176.

11.

Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings.

Hutchinson AB, Patel P, Sansom SL, Farnham PG, Sullivan TJ, Bennett B, Kerndt PR, Bolan RK, Heffelfinger JD, Prabhu VS, Branson BM.

PLoS Med. 2010 Sep 28;7(9):e1000342. doi: 10.1371/journal.pmed.1000342.

12.

HIV testing in a high-incidence population: is antibody testing alone good enough?

Stekler JD, Swenson PD, Coombs RW, Dragavon J, Thomas KK, Brennan CA, Devare SG, Wood RW, Golden MR.

Clin Infect Dis. 2009 Aug 1;49(3):444-53. doi: 10.1086/600043.

13.

Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting.

Pandori MW, Hackett J Jr, Louie B, Vallari A, Dowling T, Liska S, Klausner JD.

J Clin Microbiol. 2009 Aug;47(8):2639-42. doi: 10.1128/JCM.00119-09. Epub 2009 Jun 17.

14.

Validation, performance under field conditions, and cost-effectiveness of Capillus HIV-1/HIV-2 and determine HIV-1/2 rapid human immunodeficiency virus antibody assays using sequential and parallel testing algorithms in Tanzania.

Mayhood MK, Afwamba IA, Odhiambo CO, Ndanu E, Thielman NM, Morrissey AB, Shao JF, Wells Pence B, Crump JA.

J Clin Microbiol. 2008 Dec;46(12):3946-51. doi: 10.1128/JCM.01045-08. Epub 2008 Oct 15.

Supplemental Content

Support Center